Cargando…

STK39 enhances the progression of Cholangiocarcinoma via PI3K/AKT pathway

Serine/threonine kinase 39 (STK39) is overexpressed in various tumor tissues and plays an essential role in tumor progression. In this study, we investigated the clinical value, as well as the potential functions and mechanisms of STK39 in cholangiocarcinoma (CCA). The results showed that STK39 was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hao, Xiaopei, Zhang, Yao, Lu, Yiwei, Han, Guoyong, Rong, Dawei, Sun, Guoqiang, Sun, Guangshun, Tang, Weiwei, Wu, Jindao, Wang, Xuehao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551078/ https://www.ncbi.nlm.nih.gov/pubmed/34746696 http://dx.doi.org/10.1016/j.isci.2021.103223

Ejemplares similares

Evaluation of nodal status in intrahepatic cholangiocarcinoma: a population-based study
por: Chen, Xiaoyuan, et al.
Publicado: (2021)

Targeting Immune Cells in the Tumor Microenvironment of HCC: New Opportunities and Challenges
por: Hao, Xiaopei, et al.
Publicado: (2021)

Influence of marital status on the survival of adults with extrahepatic/intrahepatic cholangiocarcinoma
por: Chen, Zhiqiang, et al.
Publicado: (2017)

Morbidity, Prognostic Factors, and Competing Risk Nomogram for Combined Hepatocellular-Cholangiocarcinoma
por: Chen, Xiaoyuan, et al.
Publicado: (2021)

Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing
por: Hao, Xiaopei, et al.
Publicado: (2022)

CircPAK1 promotes the progression of hepatocellular carcinoma via modulation of YAP nucleus localization by interacting with 14-3-3ζ
por: Hao, Xiaopei, et al.
Publicado: (2022)

m6A modification of circHPS5 and hepatocellular carcinoma progression through HMGA2 expression
por: Rong, Dawei, et al.
Publicado: (2021)

Anlotinib suppresses tumor progression via blocking the VEGFR2/PI3K/AKT cascade in intrahepatic cholangiocarcinoma
por: Song, Fei, et al.
Publicado: (2020)

Tumor Microenvironment and its Implications for Antitumor Immunity in Cholangiocarcinoma: Future Perspectives for Novel Therapies
por: Cao, Hengsong, et al.
Publicado: (2022)

A PLCB1–PI3K–AKT Signaling Axis Activates EMT to Promote Cholangiocarcinoma Progression
por: Liang, Shuhang, et al.
Publicado: (2021)

GLIS1 intervention enhances anti-PD1 therapy for hepatocellular carcinoma by targeting SGK1-STAT3-PD1 pathway
por: Rong, Dawei, et al.
Publicado: (2023)

FER Regulated by miR-206 Promotes Hepatocellular Carcinoma Progression via NF-κB Signaling
por: Ding, Wenzhou, et al.
Publicado: (2021)

STK39 is a novel kinase contributing to the progression of hepatocellular carcinoma by the PLK1/ERK signaling pathway
por: Zhang, Chengfei, et al.
Publicado: (2021)

STK39, overexpressed in osteosarcoma, regulates osteosarcoma cell invasion and proliferation
por: Huang, Tao, et al.
Publicado: (2017)

Promising role of liver transplantation in patients with combined hepatocellular-cholangiocarcinoma: a propensity score matching analysis
por: Chen, Xiaoyuan, et al.
Publicado: (2022)

M2 macrophage-secreted exosomes promote metastasis and increase vascular permeability in hepatocellular carcinoma
por: Lu, Yiwei, et al.
Publicado: (2023)

Role of Small Molecule Targeted Compounds in Cancer: Progress, Opportunities, and Challenges
por: Sun, Guoqiang, et al.
Publicado: (2021)

STK39 and WNK1 Are Potential Hypertension Susceptibility Genes in the BELHYPGEN Cohort
por: Persu, Alexandre, et al.
Publicado: (2016)

YY1 activates EMI2 and promotes the progression of cholangiocarcinoma through the PI3K/Akt signaling axis
por: Zhou, Shuai, et al.
Publicado: (2021)

Epigenetics: Roles and therapeutic implications of non-coding RNA modifications in human cancers
por: Rong, Dawei, et al.
Publicado: (2021)

Macrophage GSK3β-deficiency inhibits the progression of hepatocellular carcinoma and enhances the sensitivity of anti-PD1 immunotherapy
por: Sun, Guangshun, et al.
Publicado: (2022)

Celastrol slows the progression of early diabetic nephropathy in rats via the PI3K/AKT pathway
por: Nie, Yusong, et al.
Publicado: (2020)

STK39 Polymorphism Is Associated with Essential Hypertension: A Systematic Review and Meta-Analysis
por: Xi, Bo, et al.
Publicado: (2013)

Genetic Association Study betweenSTK39 and CCDC62/HIP1R and Parkinson’s Disease
por: Li, Nan-Nan, et al.
Publicado: (2013)

Therapeutic targeting of ARID1A and PI3K/AKT pathway alterations in cholangiocarcinoma
por: Tessiri, Supharada, et al.
Publicado: (2022)

Tanshinone IIA affects the malignant growth of Cholangiocarcinoma cells by inhibiting the PI3K-Akt-mTOR pathway
por: Liu, Huayuan, et al.
Publicado: (2021)

MiR-3662 suppresses hepatocellular carcinoma growth through inhibition of HIF-1α-mediated Warburg effect
por: Chen, Zhiqiang, et al.
Publicado: (2018)

A meta-analytical assessment of STK39 three well-defined polymorphisms in susceptibility to hypertension
por: Yang, Hualing, et al.
Publicado: (2016)

STK39 blockage by RNA interference inhibits the proliferation and induces the apoptosis of renal cell carcinoma
por: Zhao, Qi, et al.
Publicado: (2018)

WNT5a in Colorectal Cancer: Research Progress and Challenges
por: Sun, Guangshun, et al.
Publicado: (2021)

Osthole induces apoptosis and suppresses proliferation via the PI3K/Akt pathway in intrahepatic cholangiocarcinoma
por: Zhu, Xingyang, et al.
Publicado: (2017)

MGP promotes CD8(+) T cell exhaustion by activating the NF-κB pathway leading to liver metastasis of colorectal cancer
por: Rong, Dawei, et al.
Publicado: (2022)

STK39 promotes breast cancer invasion and metastasis by increasing SNAI1 activity upon phosphorylation
por: Qiu, Zhaoping, et al.
Publicado: (2021)

Progranulin modulates cholangiocarcinoma cell proliferation, apoptosis, and motility via the PI3K/pAkt pathway
por: Daya, Minerva, et al.
Publicado: (2018)

Tetraspanin 1 promotes epithelial-to-mesenchymal transition and metastasis of cholangiocarcinoma via PI3K/AKT signaling
por: Wang, Yan, et al.
Publicado: (2018)

Overexpression of 14-3-3σ Modulates Cholangiocarcinoma Cell Survival by PI3K/Akt Signaling
por: Wu, Qiao, et al.
Publicado: (2020)

circLARP4 induces cellular senescence through regulating miR‐761/RUNX3/p53/p21 signaling in hepatocellular carcinoma
por: Chen, Zhiqiang, et al.
Publicado: (2019)

Derivation and validation of machine learning models for preoperative estimation of microvascular invasion risk in hepatocellular carcinoma
por: Chen, Zhiqiang, et al.
Publicado: (2023)

Up-regulation of MIAT aggravates the atherosclerotic damage in atherosclerosis mice through the activation of PI3K/Akt signaling pathway
por: Sun, Guoqiang, et al.
Publicado: (2019)

MicroRNA miR-451 downregulates the PI3K/AKT pathway through CAB39 in human glioma
por: TIAN, YUAN, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_tu37bp3puc4bjstus3l9b834ir